Methodology reviewed August 27, 2026 by the Ecommerce Review Hub Editorial Team
Supplements require a stricter evidence framework than ordinary consumer goods because the consequences of a weak claim are different. A pleasant texture or attractive bottle can be judged experientially; a claim about sleep, hormones, nutrient status or other health outcomes needs evidence and safety context. We therefore separate product quality, ingredient plausibility and proven clinical outcome instead of collapsing them into one “works/doesn’t work” judgment.
Our starting rule: the label is not the evidence
We first verify what the product actually contains: serving size, ingredient forms, amounts, proprietary blends, other ingredients and relevant warnings. A recognizable ingredient does not automatically mean an evidence-aligned dose, and an evidence-aligned dose does not guarantee the finished product has been shown to produce the marketed result.
The six questions behind every supplement evaluation
1. Can the formulation be understood?
Transparent labels receive more credit than proprietary blends that hide individual amounts. For botanicals we look for species, plant part, extract ratio or standardization where those details matter. For vitamins and minerals, form and dose are interpreted against the product’s intended use rather than simply rewarding higher amounts.
2. Is manufacturing quality supported?
We look for credible GMP information, lot traceability, manufacturing disclosures and quality systems. Manufacturing standards help establish consistency; they do not prove that a health claim is effective.
3. What exactly has been third-party tested?
“Third-party tested” is incomplete without scope. We distinguish identity, potency, microbes, heavy metals, pesticides, banned substances and other test categories. Formal programs such as USP or NSF are distinguished from a brand sending samples to an independent laboratory. A certificate of analysis is more useful when it is lot-specific and identifies the lab and methods.
4. What evidence supports the finished formula?
Randomized controlled trials on the actual product carry more weight than open-label studies, observational studies or ingredient-by-ingredient citations. When only ingredient evidence exists, we say so. IRB approval is an ethics safeguard, not proof of efficacy.
5. Is the claim proportionate to the evidence?
We distinguish general wellness or structure/function claims from disease-treatment language. We are cautious with words such as “clinically proven,” “detox,” “balances hormones” or “treats inflammation” when the evidence does not support the breadth of the claim.
6. Is the safety context clear?
We consider known interactions, upper intake concerns, pregnancy or breastfeeding warnings, medication issues and other circumstances where professional guidance may be appropriate. Natural origin is not treated as evidence of safety.
Our weighting approach
Formulation and dose transparency: 20%. Testing and manufacturing quality: 25%. Finished-product clinical evidence: 20%. Safety and labeling: 15%. Claims discipline and transparency: 10%. Price and practical use: 10%. These weights can shift for categories where contamination or dosing risk is unusually important.
How we treat personalized supplements
Personalization can improve relevance and user engagement, but it is not automatically more effective. We ask what information drives the recommendation, whether the assessment is validated for the claim being made, who designed the logic, whether a qualified professional is involved and how formulas change when the user’s medications or circumstances change.
Price comparisons are normalized
We compare cost per recommended daily serving and note whether the regimen requires multiple products. Subscription discounts, introductory offers and shipping are treated separately. A premium can be justified by meaningful testing, sourcing, formulation complexity or practitioner support, but not merely by “clean” positioning.
Evidence that does not receive full credit
- Animal or laboratory studies presented as direct proof of human benefit.
- Research on an ingredient at a different dose or form without qualification.
- Customer surveys framed as clinical trials.
- Third-party testing claims that do not say what was tested.
- Organic sourcing presented as proof of efficacy.
- “Doctor formulated” language with no explanation of the professional’s role or credentials.
What can materially lower or remove a recommendation
Undisclosed ingredient amounts, unsafe dosing, misleading disease claims, unresolved contamination concerns, regulatory warnings or a lack of basic label transparency can outweigh otherwise positive product attributes. In a health-related category, evidence quality and safety are not minor scoring dimensions.
Update policy
We review supplement pages when formulations, labels, serving sizes, certifications, clinical evidence, prices or safety information change. A new study can improve or weaken our confidence depending on its design and findings.
Our supplement reviews are informational and not medical advice. This methodology sits under the publication-wide How We Review standards.